Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA4 | P22748 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.32 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6553501 | 0.97 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| Ethylene SCHEMBL27505929 | 0.94 | CA1 (0.35) | CA1CA2CA4CA12CA7 | |
| Bromide SCHEMBL10982440 | 0.94 | CA1 (0.35) | CA1CA2CA4CA12CA7 | |
| Bromide SCHEMBL10982443 | 0.94 | CA1 (0.35) | CA1CA2CA4CA12CA7 | |
| Cyanide SCHEMBL21633856 | 0.91 | CA1 (0.33) | CA1CA2CA4CA12CA7 | |
| SCHEMBL28420644 | 0.87 | AKR1B1 (0.35) | CA1CA2CA4CA12CA7 | |
| SCHEMBL4601309 | 0.84 | CA12 (0.33) | CA1CA2CA12CA7CA13 | |
| Phosphoric Acid SCHEMBL28983528 | 0.84 | CA1 (0.39) | CA1CA2CA4CA12CA7 | |
| Acetonitrile SCHEMBL28945834 | 0.84 | CA1 (0.30) | CA1CA2CA4CA12CA7 | |
| SCHEMBL28498845 | 0.82 | CA1 (0.32) | CA1CA2CA4CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543319-A1 | METHOD OF MARKING HYDROCARBON LIQUIDS | Johnson Matthey Public Limited Company (GB) | 2019-09-25 | — | — | EP | claimed |
| US-20140120626-A1 | METHOD OF MARKING HYDROCARBON LIQUIDS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2014-05-01 | — | — | US | claimed |
| EP-2707465-A1 | METHOD OF MARKING HYDROCARBON LIQUIDS | Johnson Matthey Public Limited Company (GB) | 2014-03-19 | — | — | EP | claimed |
| WO-2012153132-A1 | METHOD OF MARKING HYDROCARBON LIQUIDS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-11-15 | — | — | WO | claimed |
| EP-1362860-B1 | Method for producing tetrakis (fluoraryl)borate magnesium compound | NIPPON CATALYTIC CHEM IND (JP) | 2010-09-15 | — | — | EP | claimed |
| US-7205441-B2 | Method for producing tetrakis (fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-04-17 | — | — | US | claimed |
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-11-20 | — | — | US | claimed |
| EP-1362860-A1 | Method for producing tetrakis (fluoroaryl) borate magnesium compound | Nippon Shokubai Co., Ltd. (JP) | 2003-11-19 | — | — | EP | claimed |
| CN-119264164-A | Continuous synthesis method of polyfluoroaryl borate | 吉林大学 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024175999-A2 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | DUNAD THERAPEUTICS LTD. (GB) | 2024-08-29 | — | — | WO | disclosed |
| US-20240082830-A1 | TRIARYL BORANE CATALYSTS AND METHOD FOR SELECTIVE HYDROSILYLATION OF ESTERS AND LACTONES USING SAID CATALYSTS | ALDEXCHEM KFT. (HU) | 2024-03-14 | — | — | US | disclosed |
| EP-4263560-A1 | TRIARYL BORANE CATALYSTS AND METHOD FOR SELECTIVE HYDROSILYLATION OF ESTERS AND LACTONES USING SAID CATALYSTS | AldexChem Kft. (HU) | 2023-10-25 | — | — | EP | disclosed |
| CN-116685594-A | Triarylborane catalysts and methods for selective hydrosilylation of esters and lactones using the same | 阿尔迪斯化学有限责任公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-114656466-B | Benzo-fused carbazole and indolocarbazole derivative and application of organic electroluminescent device based on benzo-fused carbazole and indolocarbazole derivative | 常州大学 | 2023-06-27 | — | — | CN | disclosed |
| WO-1995024268-A1 | METALLOCENE CATALYST CONTAINING BULKY ORGANIC GROUP | NORTHWESTERN UNIVERSITY (US) | 1995-09-14 | — | — | WO | disclosed |
| CN-1014061-B | The preparation method of pyrimidine derivatives | ICI PLC (GB) | 1991-09-25 | — | — | CN | disclosed |
| CN-86108825-A | PYRIMIDINE DERIVATIVES | — | 1987-07-22 | — | — | CN | disclosed |
| EP-0109606-B1 | PROCESS FOR THE FORMYLATION OF ARYL HALIDES | BAYER AG (DE) | 1986-01-22 | — | — | EP | disclosed |
| US-4536344-A | USING A PHOSPINE OR PHOSPHITE | BAYER AKTIENGESELLSCHAFT (DE) | 1985-08-20 | — | — | US | disclosed |
| EP-0109606-A1 | Process for the formylation of aryl halides | BAYER AG (DE) | 1984-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216598-A1 | Method for producing tetrakis ( fluoroaryl) borate-magnesium compound | KRAS, MGAM, CA3 | CA1 190/4885CA2 119/4885CA4 257/4885 |
| US-20240082830-A1 | TRIARYL BORANE CATALYSTS AND METHOD FOR SELECTIVE HYDROSILYLATION OF ESTERS AND LACTONES USING SAID CATALYSTS | TREH, STS, LSS | CA1 735/4885CA2 1729/4885CA4 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.